Zhang R, Wei R, Yuan Y, Li N, Hu Y, Chan K
JGH Open. 2024; 8(7):e13039.
PMID: 39006099
PMC: 11239974.
DOI: 10.1002/jgh3.13039.
Lu R, Zhao Y, Radisic M
Bioeng Transl Med. 2024; 9(3):e10581.
PMID: 38818123
PMC: 11135153.
DOI: 10.1002/btm2.10581.
Chen S, Fu Z, Chen K, Zheng X, Fu Z
BMC Genomics. 2024; 25(1):271.
PMID: 38475718
PMC: 10936015.
DOI: 10.1186/s12864-024-10194-5.
Garcia-Gonzalez L, Marti-Sarrias A, Puertas M, Bayon-Gil A, Resa-Infante P, Martinez-Picado J
Dis Model Mech. 2023; 16(7).
PMID: 37458167
PMC: 10387352.
DOI: 10.1242/dmm.050049.
Tang X, Xue D, Zhang T, Nilsson-Payant B, Carrau L, Duan X
Nat Cell Biol. 2023; 25(3):381-389.
PMID: 36918693
PMC: 10014579.
DOI: 10.1038/s41556-023-01095-y.
COVID-19: The Many Ways to Hurt Your Heart.
Akter A, Clemente-Casares X
Viruses. 2023; 15(2).
PMID: 36851629
PMC: 9968223.
DOI: 10.3390/v15020416.
Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research.
Karami Z, Moradi S, Eidi A, Soleimani M, Jafarian A
Front Cell Dev Biol. 2023; 10:1050856.
PMID: 36733338
PMC: 9887183.
DOI: 10.3389/fcell.2022.1050856.
Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications.
Wong C, Lam T, Liao S, Lau Y, Tse H, So B
Biomedicines. 2023; 11(1).
PMID: 36672615
PMC: 9855410.
DOI: 10.3390/biomedicines11010107.
Long COVID-19 and the Heart: Is Cardiac Mitochondria the Missing Link?.
Chang X, Ismail N, Rahman A, Xu D, Chan R, Ong S
Antioxid Redox Signal. 2022; 38(7-9):599-618.
PMID: 36053670
PMC: 10025846.
DOI: 10.1089/ars.2022.0126.
Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells.
Khedro T, Duran J, Adler E
Curr Cardiol Rep. 2022; 24(6):631-644.
PMID: 35657495
PMC: 9164178.
DOI: 10.1007/s11886-022-01683-8.
Angiotensin converting enzyme and sodium glucose cotransporter inhibitors alleviate inflammatory effects of SARS-CoV-2 in cardiomyocytes.
Wong C, Lau Y, Lai W, Zhang R, Luk H, Wong A
Cardiol J. 2022; 29(4):702-706.
PMID: 35578759
PMC: 9273252.
DOI: 10.5603/CJ.a2022.0033.
COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.
Martinez-Salazar B, Holwerda M, Studle C, Piragyte I, Mercader N, Engelhardt B
Front Cell Dev Biol. 2022; 10:824851.
PMID: 35242762
PMC: 8887620.
DOI: 10.3389/fcell.2022.824851.
The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury.
Siripanthong B, Asatryan B, Hanff T, Chatha S, Khanji M, Ricci F
JACC Basic Transl Sci. 2022; 7(3):294-308.
PMID: 35165665
PMC: 8828362.
DOI: 10.1016/j.jacbts.2021.10.011.
Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating.
Salerno J, Torquato T, Temerozo J, Goto-Silva L, Karmirian K, Mendes M
PeerJ. 2022; 9:e12595.
PMID: 35036128
PMC: 8697769.
DOI: 10.7717/peerj.12595.
Hypertension and its management in COVID-19 patients: The assorted view.
El-Saber Batiha G, Gari A, Elshony N, Shaheen H, Abubakar M, Adeyemi S
Int J Cardiol Cardiovasc Risk Prev. 2021; 11:200121.
PMID: 34806090
PMC: 8590508.
DOI: 10.1016/j.ijcrp.2021.200121.
Recent Advances of COVID-19 Modeling Based on Regenerative Medicine.
Larijani B, Foroughi-Heravani N, Abedi M, Tayanloo-Beik A, Rezaei-Tavirani M, Adibi H
Front Cell Dev Biol. 2021; 9:683619.
PMID: 34760882
PMC: 8573217.
DOI: 10.3389/fcell.2021.683619.
WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2.
Aragao L, Oliveira J, Temerozo J, Mendes M, Salerno J, Pedrosa C
PeerJ. 2021; 9:e12262.
PMID: 34707939
PMC: 8504461.
DOI: 10.7717/peerj.12262.
Stem Cells as a Model of Study of SARS-CoV-2 and COVID-19: A Systematic Review of the Literature.
Cuevas-Gonzalez M, Garcia-Perez A, Gonzalez-Aragon Pineda A, Espinosa-Cristobal L, Donohue-Cornejo A, Tovar-Carrillo K
Biomed Res Int. 2021; 2021:9915927.
PMID: 34458372
PMC: 8390136.
DOI: 10.1155/2021/9915927.
The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications.
Veluswamy P, Wacker M, Stavridis D, Reichel T, Schmidt H, Scherner M
Viruses. 2021; 13(7).
PMID: 34372552
PMC: 8310117.
DOI: 10.3390/v13071346.
Network pharmacology and RNA-sequencing reveal the molecular mechanism of Xuebijing injection on COVID-19-induced cardiac dysfunction.
He D, Zhang X, Zhu X, Huang F, Wang Z, Tu J
Comput Biol Med. 2021; 131:104293.
PMID: 33662681
PMC: 7899014.
DOI: 10.1016/j.compbiomed.2021.104293.
